Related Experiment Video
Updated: Jun 13, 2026
10:05
A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
Published on: March 18, 2021
The role of the complement system in CNS inflammatory diseases
Philip F Stahel1, Scott R Barnum
1Department of Orthopedic Surgery, Denver Health Medical Center, University of Colorado School of Medicine, Denver, CO 80204, USA. pfstahel@aol.com
Expert Review of Clinical Immunology
|May 19, 2010
Summary
Complement, part of the immune system, can harm the central nervous system (CNS). Inhibiting complement shows promise for treating CNS diseases, offering new therapeutic strategies.
Area of Science:
- Neuroimmunology
- Innate and adaptive immunity
- Complement system
Background:
- Complement proteins are crucial for host defense via inflammation, phagocytosis, and cell lysis.
- In the central nervous system (CNS), complement activation can paradoxically cause inflammation and tissue damage, leading to neurological deficits.
- Dysregulation of the complement system is implicated in the pathogenesis of various CNS diseases.
Purpose of the Study:
- To review the role of the complement system in CNS diseases.
- To discuss the therapeutic potential of targeted complement inhibition in CNS disorders.
- To explore the complexities and emerging strategies for complement-targeted therapies in the CNS.
Main Methods:
- Literature review of recent advancements in complement research and CNS disease models.
- Analysis of studies investigating complement inhibitors in preclinical and clinical settings.
- Synthesis of current understanding regarding complement's dual role in host defense and neuropathology.
Main Results:
- The complement system plays a significant role in both protective immunity and detrimental inflammation within the CNS.
- Targeted inhibition of specific complement components has emerged as a promising therapeutic avenue.
- Development of novel complement inhibitors and sophisticated animal models has advanced this field.
Conclusions:
- Targeted complement inhibition represents a significant emerging therapeutic strategy for CNS diseases.
- Understanding the nuances of complement activation in the CNS is critical for effective therapeutic intervention.
- Further research into complement pathways holds potential for developing innovative treatments for neurological disorders.
Related Concept Videos
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...